HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manfred Hensel Selected Research

Pentostatin (Nipent)

1/2015Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemia.
4/2006Pentostatin for the treatment of indolent lymphoproliferative disorders.
4/2006Pentostatin and purine analogs for indolent lymphoid malignancies.
9/2005Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
5/2003Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manfred Hensel Research Topics

Disease

11Neoplasms (Cancer)
01/2021 - 01/2002
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 01/2002
9Lymphoma (Lymphomas)
10/2019 - 01/2002
6Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2018 - 11/2004
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2011 - 01/2002
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 01/2007
4Infections
01/2020 - 08/2003
4Multiple Myeloma
01/2020 - 09/2010
4Leukemia
01/2009 - 01/2002
3Body Weight (Weight, Body)
05/2016 - 01/2002
2Residual Neoplasm
01/2021 - 06/2006
2Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 02/2011
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2015 - 12/2006
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2015 - 09/2005
2Acquired Immunodeficiency Syndrome (AIDS)
06/2014 - 02/2011
2Autoimmune Diseases (Autoimmune Disease)
01/2013 - 09/2010
2Guillain-Barre Syndrome
01/2013 - 09/2010
2Polyneuropathies (Polyneuropathy)
01/2013 - 09/2010
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2013 - 09/2010
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2007 - 05/2003
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2006 - 05/2003
2Hairy Cell Leukemia
04/2006 - 05/2003
2Breast Neoplasms (Breast Cancer)
07/2002 - 01/2002
1IgG Deficiency
01/2020
1Obesity
01/2020
1Trisomy (Trisomies)
01/2018
1Sudden Infant Death (SID)
08/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2015
1Primary Effusion Lymphoma
06/2014
1Lung Neoplasms (Lung Cancer)
10/2013
1Hodgkin Disease (Hodgkin's Disease)
02/2011
1Carcinoma (Carcinomatosis)
02/2011
1Chronic Disease (Chronic Diseases)
01/2009
1T-Cell Leukemia (Leukemia, T Cell)
04/2006
1Cytopenia
04/2006
1T-Cell Lymphoma (Lymphoma, T Cell)
09/2005
1B-Cell Leukemia (Leukemia, B Cell)
11/2004
1Virus Diseases (Viral Diseases)
08/2003
1Splenomegaly
08/2003
1Systemic Vasculitis
01/2003
1Thrombocytopenia (Thrombopenia)
11/2002
1Fever (Fevers)
11/2002
1Hemorrhage
11/2002

Drug/Important Bio-Agent (IBA)

17Rituximab (Mabthera)FDA Link
01/2020 - 01/2002
6purineIBA
01/2015 - 05/2003
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 01/2003
5Pentostatin (Nipent)FDA LinkGeneric
01/2015 - 05/2003
4Pharmaceutical PreparationsIBA
01/2018 - 05/2003
4Immunoglobulins (Immunoglobulin)IBA
08/2017 - 08/2003
4fludarabineIBA
01/2017 - 11/2002
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 08/2003
2Immunomodulating AgentsIBA
01/2020 - 11/2019
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2020 - 05/2016
2Immunoglobulin G (IgG)IBA
01/2020 - 09/2010
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2019 - 08/2003
2Alkylating AgentsIBA
01/2015 - 04/2006
2Biological ProductsIBA
06/2006 - 07/2002
2Proteins (Proteins, Gene)FDA Link
07/2002 - 01/2002
2DNA (Deoxyribonucleic Acid)IBA
07/2002 - 01/2002
2ParaffinIBA
07/2002 - 01/2002
2Formaldehyde (Formol)FDA Link
07/2002 - 01/2002
1ofatumumabFDA Link
01/2021
1NucleosidesIBA
01/2021
1ibrutinibIBA
01/2021
1Bendamustine HydrochlorideFDA Link
01/2021
1Phosphotransferases (Kinase)IBA
01/2018
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1CD20 AntigensIBA
02/2011
1NAD (NADH)IBA
02/2011
1Alemtuzumab (Campath)FDA Link
08/2009
1Prednisone (Sone)FDA LinkGeneric
09/2008
1Etoposide (VP 16)FDA LinkGeneric
09/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2008
1Inosine Triphosphate (ITP)IBA
10/2007
1AutoantibodiesIBA
10/2007
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2007
1Cisplatin (Platino)FDA LinkGeneric
10/2006
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2006
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2006
1Adenosine DeaminaseIBA
04/2006
1Immunoglobulin M (IgM)IBA
09/2005
1AntigensIBA
11/2004
1Monoclonal AntibodiesIBA
08/2003
1CladribineFDA LinkGeneric
05/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2003

Therapy/Procedure

16Therapeutics
05/2019 - 08/2003
9Drug Therapy (Chemotherapy)
07/2018 - 01/2002
7Stem Cell Transplantation
07/2018 - 01/2002
2Immunotherapy
02/2011 - 11/2004
2Radiotherapy
02/2011 - 07/2010
2Salvage Therapy
12/2006 - 10/2006
1Art Therapy
10/2013
1Ambulatory Care (Outpatient Care)
02/2011
1Immunomodulation
09/2010
1Complementary Therapies (Alternative Medicine)
01/2009
1Autologous Transplantation
01/2007
1Transplantation
01/2007
1Combination Drug Therapy (Combination Chemotherapy)
02/2006
1Aftercare (After-Treatment)
05/2003